Cargando…

A Role for Estrogen in Schizophrenia: Clinical and Preclinical Findings

Gender differences in schizophrenia have been extensively researched and it is being increasingly accepted that gonadal steroids are strongly attributed to this phenomenon. Of the various hormones implicated, the estrogen hypothesis has been the most widely researched one and it postulates that estr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gogos, Andrea, Sbisa, Alyssa M., Sun, Jeehae, Gibbons, Andrew, Udawela, Madhara, Dean, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600562/ https://www.ncbi.nlm.nih.gov/pubmed/26491441 http://dx.doi.org/10.1155/2015/615356

Ejemplares similares

Studies on Prostaglandin-Endoperoxide Synthase 1: Lower Levels in Schizophrenia and After Treatment with Antipsychotic Drugs in Conjunction with Aspirin
por: Dean, Brian, et al.
Publicado: (2017)

Non-Coding RNA as Novel Players in the Pathophysiology of Schizophrenia
por: Gibbons, Andrew, et al.
Publicado: (2018)

Validating reference genes using minimally transformed qpcr data: findings in human cortex and outcomes in schizophrenia
por: Dean, Brian, et al.
Publicado: (2016)

Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders
por: Parkin, Georgia M, et al.
Publicado: (2018)

PM483. Gene expression changes in the rat frontal cortex caused by sex steroid hormones
por: Gogos, Andrea, et al.
Publicado: (2016)

Changed frontal pole gene expression suggest altered interplay between neurotransmitter, developmental, and inflammatory pathways in schizophrenia
por: Scarr, Elizabeth, et al.
Publicado: (2018)

Cholinergic connectivity: it's implications for psychiatric disorders
por: Scarr, Elizabeth, et al.
Publicado: (2013)

The effect of estrogenic compounds on psychosis-like behaviour in female rats
por: Sbisa, Alyssa, et al.
Publicado: (2018)

The Impact of Removal of Ovarian Hormones on Cholinergic Muscarinic Receptors: Examining Prepulse Inhibition and Receptor Binding
por: Ch’ng, Sarah S., et al.
Publicado: (2020)

Autophagy has a key role in the pathophysiology of schizophrenia
por: Merenlender-Wagner, A, et al.
Publicado: (2015)

Increased cortical expression of the zinc transporter SLC39A12 suggests a breakdown in zinc cellular homeostasis as part of the pathophysiology of schizophrenia
por: Scarr, Elizabeth, et al.
Publicado: (2016)

Evidence for impaired glucose metabolism in the striatum, obtained postmortem, from some subjects with schizophrenia
por: Dean, B, et al.
Publicado: (2016)

Widespread Changes in Positive Allosteric Modulation of the Muscarinic M(1) Receptor in Some Participants With Schizophrenia
por: Hopper, Shaun, et al.
Publicado: (2019)

The Role of Estrogen in the Treatment of Men with Schizophrenia
por: Kulkarni, Jayashri, et al.
Publicado: (2013)

SELENBP1 expression in the prefrontal cortex of subjects with schizophrenia
por: Udawela, M, et al.
Publicado: (2015)

Changed gene expression in subjects with schizophrenia and low cortical muscarinic M1 receptors predicts disrupted upstream pathways interacting with that receptor
por: Scarr, E, et al.
Publicado: (2018)

PM490. Upregulation of zinc transporter, solute carrier family 39, member 12, in the cortex of subjects with schizophrenia
por: Udawela, M, et al.
Publicado: (2016)

Low Density Lipoprotein Receptor-Related Protein and Apolipoprotein E Expression is Altered in Schizophrenia
por: Gibbons, Andrew Stuart, et al.
Publicado: (2010)

Synaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia
por: Crabtree, Gregg W., et al.
Publicado: (2014)

Diabetes and Sepsis: Preclinical Findings and Clinical Relevance
por: Schuetz, Philipp, et al.
Publicado: (2011)

Isoform specific differences in phospholipase C beta 1 expression in the prefrontal cortex in schizophrenia and suicide
por: Udawela, M., et al.
Publicado: (2017)

Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis
por: Chana, Gursharan, et al.
Publicado: (2013)

Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings
por: Kesner, Andrew J., et al.
Publicado: (2021)

Biomarkers of Migraine: An Integrated Evaluation of Preclinical and Clinical Findings
por: Demartini, Chiara, et al.
Publicado: (2023)

Estrogens in schizophrenia: progress, current challenges and opportunities
por: Brand, Bodyl A., et al.
Publicado: (2021)

Estrogens in schizophrenia: What do we know?
por: Ferreira, L. Paulino, et al.
Publicado: (2021)

A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression
por: Cheng, Julia N., et al.
Publicado: (2021)

Cognitive Deficits in Schizophrenia and Other Neuropsychiatric Disorders: Convergence of Preclinical and Clinical Evidence
por: Stuchlik, Ales, et al.
Publicado: (2014)

A year in heart failure: updates of clinical and preclinical findings
por: Bäck, Magnus, et al.
Publicado: (2023)

Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue
por: Lai, C-Y, et al.
Publicado: (2016)

Dissecting the Syndrome of Schizophrenia: Progress toward Clinically Useful Biomarkers
por: Dean, Brian
Publicado: (2011)

Association of Increased Prenatal Estrogen With Risk Factors for Schizophrenia
por: Brown, James S.
Publicado: (2011)

The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy
por: Iorga, Andrea, et al.
Publicado: (2017)

S32. ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS POTENTIAL THERAPEUTICS FOR SCHIZOPHRENIA?
por: Breier, Alan, et al.
Publicado: (2020)

Altered corollary discharge signaling in the auditory cortex of a mouse model of schizophrenia predisposition
por: Rummell, Brian P., et al.
Publicado: (2023)

Reward learning as a potential target for pharmacological augmentation of cognitive remediation for schizophrenia: a roadmap for preclinical development
por: Acheson, Dean T., et al.
Publicado: (2013)

Adult Neurogenesis in Epileptogenesis: An Update for Preclinical Finding and Potential Clinical Translation
por: Chen, Liying, et al.
Publicado: (2020)

Pharmacological Mechanisms Involved in Sensory Gating Disruption Induced by (±)-3,4-Methylene- Dioxymethamphetamine (MDMA): Relevance to Schizophrenia
por: Lee, Jaime, et al.
Publicado: (2020)

Nicotine consumption during the prodromal phase of schizophrenia – a review of the literature
por: Gogos, Athanasios, et al.
Publicado: (2019)

Using iPSC Models to Understand the Role of Estrogen in Neuron–Glia Interactions in Schizophrenia and Bipolar Disorder
por: Reis de Assis, Denis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6jfmom0padamnpmp7ejh3quiln